Zdrowie i gospodarka · 04/11/1998

FDA Updates Tamper-Evident Packaging Requirements for Over-the-Counter Human Drug Products

The Food and Drug Administration (FDA) is amending its regulations to require tamper-evident packaging for over-the-counter (OTC) human drug products in two-piece, hard gelatin capsules, and to update labeling to reflect this change, in an effort to improve consumer protection and address vulnerabilities in the OTC drug market.